Annual Shareholders Equity
$31.21 M
-$21.08 M-40.31%
December 31, 2021
Summary
- As of February 10, 2025, ETTX annual stockholders equity is $31.21 million, with the most recent change of -$21.08 million (-40.31%) on December 31, 2021.
- During the last 3 years, ETTX annual shareholders equity has fallen by -$51.67 million (-62.34%).
Performance
ETTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$16.65 M
-$14.56 M-46.66%
March 31, 2022
Summary
- As of February 10, 2025, ETTX quarterly stockholders equity is $16.65 million, with the most recent change of -$14.56 million (-46.66%) on March 31, 2022.
- Over the past year, ETTX quarterly shareholders equity has dropped by -$27.61 million (-62.39%).
Performance
ETTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ETTX Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -40.3% | -62.4% |
3 y3 years | -62.3% | -76.4% |
5 y5 years | -36.2% | - |
ETTX Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | -46.7% | at low |
5 y | 5-year | -40.3% | at low | -73.3% | at low |
alltime | all time | -62.3% | -184.4% | -81.6% | at low |
Entasis Therapeutics Holdings Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $16.65 M(-46.7%) |
Dec 2021 | $31.21 M(-40.3%) | $31.21 M(-24.3%) |
Sep 2021 | - | $41.23 M(-22.3%) |
Jun 2021 | - | $53.06 M(+19.9%) |
Mar 2021 | - | $44.26 M(-15.4%) |
Dec 2020 | $52.29 M(+24.0%) | $52.29 M(-16.0%) |
Sep 2020 | - | $62.24 M(+26.3%) |
Jun 2020 | - | $49.29 M(+77.9%) |
Mar 2020 | - | $27.70 M(-34.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $42.16 M(-49.1%) | $42.16 M(-23.2%) |
Sep 2019 | - | $54.89 M(-5.1%) |
Jun 2019 | - | $57.84 M(-18.0%) |
Mar 2019 | - | $70.57 M(-14.9%) |
Dec 2018 | $82.88 M(+69.4%) | $82.88 M(-8.4%) |
Sep 2018 | - | $90.48 M(+174.2%) |
Jun 2018 | - | $33.00 M(-32.6%) |
Dec 2017 | $48.92 M(-285.7%) | $48.92 M |
Dec 2016 | -$26.34 M | - |
FAQ
- What is Entasis Therapeutics Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings annual shareholders equity year-on-year change?
- What is Entasis Therapeutics Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Entasis Therapeutics Holdings?
- What is Entasis Therapeutics Holdings quarterly shareholders equity year-on-year change?
What is Entasis Therapeutics Holdings annual stockholders equity?
The current annual shareholders equity of ETTX is $31.21 M
What is the all time high annual shareholders equity for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high annual stockholders equity is $82.88 M
What is Entasis Therapeutics Holdings annual shareholders equity year-on-year change?
Over the past year, ETTX annual stockholders equity has changed by -$21.08 M (-40.31%)
What is Entasis Therapeutics Holdings quarterly stockholders equity?
The current quarterly shareholders equity of ETTX is $16.65 M
What is the all time high quarterly shareholders equity for Entasis Therapeutics Holdings?
Entasis Therapeutics Holdings all-time high quarterly stockholders equity is $90.48 M
What is Entasis Therapeutics Holdings quarterly shareholders equity year-on-year change?
Over the past year, ETTX quarterly stockholders equity has changed by -$27.61 M (-62.39%)